http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-388101-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 1986-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AT-388101-B
titleOfInvention METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE SUBSTANCE RELEASE
abstract A process for the production of a pharmaceutical composition for oral administration with controlled release of the active ingredient, with addition of swelling agents and fatty materials is described and entails a 9,10-dihydro-ergot alkaloid active ingredient being mixed with a hydrophilic, swellable, pharmaceutically acceptable substance and with a pharmaceutically acceptable fatty material, and where appropriate with other additives and, where appropriate, being further processed to capsules or tablets.
priorityDate 1985-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2553026-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3246492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4199560-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10889
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416028789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID592735
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID482950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71171
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID482950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447508948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590429
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743273

Total number of triples: 44.